Company: ZVRA
Filing Date: 2025-03-31
Form Type: PREC14A
Source: 0001193125-25-068746
Chunk: 70

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: PREC14A
Chunk 70
---
 immediately prior to a change in control of the Company, subject in each case to the director’s continued service on such vesting date. In addition to the amounts above, upon the commencement of a non-employee director’s initial term of service to the Board, such individual will automatically be granted a stock option covering 1.5 times the number of shares covering the annual grants to non-employee directors. The initial grants will vest and become exercisable in three equal installments on the date that is one day prior to the date of the first three annual meeting of stockholders following the date of grant, subject to accelerated vesting upon a change in control of the Company (and, in each case, subject to continued service on the Board). Following the annual non-employeedirector compensation policy reviews undertaken by the Board, and based upon the recommendation of the Compensation Committee after consultation with Alpine, the Board elected to revise the policy, effective February 15, 2025 (the Tenth Amended and Restated Non-Employee Director Compensation Policy). The table below summarizes cash compensation to be paid under the policy as amended. 69

|                                                 |     |   Member Annual 
 Service Stipend |     |               Chairman 
 Annual Service Stipend |
| Board of Directors                              |     |         $45,000 |     |                $95,000 |
| Audit Committee                                 |     |         $10,000 |     |                $22,500 |
| Compensation Committee                          |     |          $7,500 |     |                $15,000 |
| Nominating and Corporate Governance Committee   |     |          $5,000 |     |                $12,500 |
| Lead independent director (if one is appointed) |     |         $15,000 |     |                      - |

Additionally, the Board revised the policy so that options will be granted equally to all Board members (including the Chair) and reduced the number of shares subject to annual option grants under the policy to 30,000 for all Board members (including the Chair). 2024 DIRECTOR COMPENSATION TABLE The following table sets forth information regarding compensation earned for service on our Board during 2024 by our non-employeedirectors. Mr. McFarlane, our President and Chief Executive Officer, was also a director during 2024 but did not receive any additional compensation for his service as a director. Mr. McFarlane’s compensation as an executive officer is set forth above under “Executive Compensation—2024